These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24691491)

  • 1. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
    Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
    Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13.
    Xu W; Wan Q; Na S; Yokota H; Yan JL; Hamamura K
    Cell Signal; 2015 Dec; 27(12):2332-42. PubMed ID: 26303573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF2α-Independent Inhibition of TNF-α-Triggered NF-κB Activation by Salubrinal.
    Nakajima S; Chi Y; Gao K; Kono K; Yao J
    Biol Pharm Bull; 2015; 38(9):1368-74. PubMed ID: 26328492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.
    Hamamura K; Tanjung N; Yokota H
    J Bone Miner Metab; 2013 Nov; 31(6):618-28. PubMed ID: 23536193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eukaryotic initiation factor 2α--a downstream effector of mammalian target of rapamycin--modulates DNA repair and cancer response to treatment.
    Tuval-Kochen L; Paglin S; Keshet G; Lerenthal Y; Nakar C; Golani T; Toren A; Yahalom J; Pfeffer R; Lawrence Y
    PLoS One; 2013; 8(10):e77260. PubMed ID: 24204783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation initiation factor 2 subunit α (eIF2α) inhibitor salubrinal attenuates paraquat-induced human lung epithelial-like A549 cell apoptosis by regulating the PERK-eIF2α signaling pathway.
    Wang R; Sun DZ; Song CQ; Xu YM; Liu W; Liu Z; Dong XS
    Toxicol In Vitro; 2018 Feb; 46():58-65. PubMed ID: 28986289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salubrinal protects against Clostridium difficile toxin B-induced CT26 cell death.
    Chen S; Sun C; Gu H; Wang H; Li S; Ma Y; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):228-237. PubMed ID: 28119311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of salubrinal on cadmium-induced apoptosis in HK-2 human renal proximal tubular cells.
    Komoike Y; Inamura H; Matsuoka M
    Arch Toxicol; 2012 Jan; 86(1):37-44. PubMed ID: 21809093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model.
    Wu CT; Sheu ML; Tsai KS; Chiang CK; Liu SH
    Free Radic Biol Med; 2011 Aug; 51(3):671-80. PubMed ID: 21616140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells.
    Koizumi M; Tanjung NG; Chen A; Dynlacht JR; Garrett J; Yoshioka Y; Ogawa K; Teshima T; Yokota H
    Anticancer Res; 2012 Sep; 32(9):3667-73. PubMed ID: 22993304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.
    Zhao X; Zhang C; Zhou H; Xiao B; Cheng Y; Wang J; Yao F; Duan C; Chen R; Liu Y; Feng C; Li H; Li J; Dai R
    Oncotarget; 2016 Dec; 7(51):85492-85501. PubMed ID: 27863431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salubrinal Suppresses IL-17-Induced Upregulation of MMP-13 and Extracellular Matrix Degradation Through the NF-kB Pathway in Human Nucleus Pulposus Cells.
    Yao Z; Nie L; Zhao Y; Zhang Y; Liu Y; Li J; Cheng L
    Inflammation; 2016 Dec; 39(6):1997-2007. PubMed ID: 27590238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling.
    Takigawa S; Chen A; Nishimura A; Liu S; Li BY; Sudo A; Yokota H; Hamamura K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
    Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
    Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.
    Jeon YJ; Kim JH; Shin JI; Jeong M; Cho J; Lee K
    Mol Cells; 2016 Feb; 39(2):129-35. PubMed ID: 26743901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage.
    Matsuoka M; Komoike Y
    Int J Mol Sci; 2015 Jul; 16(7):16275-87. PubMed ID: 26193263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
    Konrad C; Queener SF; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1815-22. PubMed ID: 23380722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.